Tandem Diabetes Care (TNDM) Amortization of Deferred Charges (2013 - 2026)
Tandem Diabetes Care's (TNDM) quarterly Amortization of Deferred Charges came in at $809000.0 in Q2 2026, up 73.98% on a YoY basis from $465000.0 in Q2 2025, and up 40.45% quarter-over-quarter from $576000.0 in Q1 2026.
Powered by 
Analysis
Tandem Diabetes Care (TNDM) Amortization of Deferred Charges (2013 - 2026) Analysis & Trends
Tandem Diabetes Care (TNDM) has reported Amortization of Deferred Charges for 13 consecutive years, with $809000.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Amortization of Deferred Charges rose 73.98% year-over-year to $809000.0; the trailing twelve-month figure through Jun 2026 stood at $2.3 million (up 15.25% YoY), and the FY2025 full-year result was $1.9 million, down 10.96% from the prior year.
- Amortization of Deferred Charges climbed to $809000.0 in Q2 2026 per TNDM's latest filing, from $576000.0 in the prior quarter.
- Across five years, Amortization of Deferred Charges topped out at $809000.0 in Q2 2026 and bottomed at $435000.0 in Q2 2024.
- Historically, Amortization of Deferred Charges has averaged $520944.4 across 5 years, with a median of $499500.0 in 2022.
- The sharpest annual moves came in 2024 and 2026: Amortization of Deferred Charges dropped 28.49% in 2024, then surged 73.98% in 2026.
- Over 5 years, Amortization of Deferred Charges stood at $501000.0 in 2022, then slipped by 1.6% to $493000.0 in 2023, then climbed by 1.83% to $502000.0 in 2024, then declined by 11.16% to $446000.0 in 2025, then surged by 81.39% to $809000.0 in 2026.
- According to Business Quant data, Amortization of Deferred Charges over the past three periods registered $809000.0, $576000.0, and $446000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.78 Bn | 175.17 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.04 Bn | 121.82 Bn | 1.96 Bn |
| 3 | Medtronic | 117.04 Bn | 108.22 Bn | 6.34 Bn |
| 4 | Stryker | 103.86 Bn | 100.38 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.50 Bn | 62.96 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.74 Bn | 45.49 Bn | 1.35 Bn |
| 7 | Alcon | 32.99 Bn | 31.53 Bn | 1.68 Bn |
| 8 | Dexcom | 32.12 Bn | 30.17 Bn | 830.00 Mn |
| 9 | Steris | 20.69 Bn | 20.21 Bn | 684.20 Mn |
| 10 | Tandem Diabetes Care | 1.27 Bn | 811.05 Mn | 144.78 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 809,000.00 |
| Mar 31, 2026 | 576,000.00 |
| Dec 31, 2025 | 446,000.00 |
| Sep 30, 2025 | 444,000.00 |
| Jun 30, 2025 | 465,000.00 |
| Mar 31, 2025 | 505,000.00 |
| Dec 31, 2024 | 502,000.00 |
| Sep 30, 2024 | 502,000.00 |
| Jun 30, 2024 | 435,000.00 |
| Mar 31, 2024 | 650,000.00 |
| Dec 31, 2023 | 493,000.00 |
| Sep 30, 2023 | 702,000.00 |
| Jun 30, 2023 | 450,000.00 |
| Mar 31, 2023 | 503,000.00 |
| Dec 31, 2022 | 501,000.00 |
| Sep 30, 2022 | 498,000.00 |
| Jun 30, 2022 | 458,000.00 |
| Mar 31, 2022 | 438,000.00 |
| Dec 31, 2021 | 435,000.00 |
| Sep 30, 2021 | 433,000.00 |